An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum

Indian Journal of Dermatology, Venereology and Leprology

Volumn 74, Issue 6, 2008, Pages 614-618

  Metkar, Amol ^a   Pande, Sushil ^a   Khopkar, Uday ^a  

^a KEM HOSPITAL   (India)

Author keywords

Imiquimod; Molluscum contagiosum; Potassium hydroxide

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; IMIQUAD; IMIQUIMOD; POTASSIUM HYDROXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BEDTIME DOSAGE; BURN; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; EROSION; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; GRAM STAINING; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; LONGITUDINAL STUDY; MALE; MOLLUSCUM CONTAGIOSUM; MYALGIA; OPEN STUDY; PARENT; PRURITUS; SKIN CRUSTING; SKIN INFLAMMATION; SKIN PAIN; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOQUINOLINES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROXIDES; LONGITUDINAL STUDIES; MALE; MOLLUSCUM CONTAGIOSUM; PHARMACEUTICAL SOLUTIONS; PIGMENTATION DISORDERS; POTASSIUM COMPOUNDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59149097754     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.45104     Document Type: Article

References (14)

1. Bunney MH, Nolan MW, Williams DA. An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. Br J Dermatol 1976;94:667-79.
2. Phelps WC, Alexander KA, Antiviral therapy for human papillomaviruses: Rationale and prospects. Ann Intern Med 1995;123:368-82.
3. Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. Br J Dermatol 2003;149:25-28.
4. Goldman L. Dermatologic surgery in an ambulatory surgery center: Ten years. experience. Cutis 1984 34:65-6,68.
5. Romiti R, Ribeiro AP, Grinblat GM. Treatment of molluscum contagiosum with potassium hydroxide: A clinical approach in 35 children. Pediatr Dermatol 1999;16:228-31.
6. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol 1998;38:230-9.
7. Edwards L, Ferenczy A, Eron L, Baker O, Owens ML, Fox TL, et al. Self administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30.
8. Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, et al. A randomized, controlled, molecular study of condylomata acuminate clearance during treatment with imiquimod. J Infect Dis 1998;178:551-5.
9. Arany I, Tyring SK. Activation of local cell mediated immunity in interferon responsive patients with human papillomavirus-associated lesions. J Interferon Cytokine Res 1996;16:453-60.
10. Spradbrow PB. Immune response to papillomaviruses infection. In: Syrjänen K, Gissmann L, Koss LG, editors. Papillomaviruses and human disease. Berlin: Springer-Verlag, 1987. p. 334-70.
11. Syed TA, Goswami J, Ahmadour O, et al. Treatment of molluscum contagiosum, in males with an analog of imiquimod 1% in cream. J Dermatol (Tokyo) 1998;25:309-13.
12. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J 2006;7:20.
13. Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, et al. Self administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026-31.
14. Romiti R, Ribeiro AP, Romiti N. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol 2000;17:495.